Regulation FD Disclosure Form 8 K

Over the last several days, NWBio has received inquiries and messages from a number of shareholders regarding several rumors being passed around social media platforms relating to our business outlook. Some of the shareholder messages have identified a potential connection between these rumors and certain parties associated with the lawsuit we are currently pursuing in federal court in NY.

While it is our standard practice not to comment on rumors, we have noted the coincidence of timing between these rumors and certain developments in the market relating to our stock. We are investigating the source(s) of these rumors and we plan to pursue appropriate action. We request that our shareholders continue to send us any information related to the rumors, the parties who are spreading them, and related matters.

We also ask that our shareholders and all interested parties carefully consider the source(s) of rumors, their reliability and their self-interests before forming a judgment about them. There are several high profile court cases pending that involve the use of these types of tactics in order to negatively impact a company's stock, and high profile civil and criminal enforcement actions in this arena have recently commenced. We advise caution in evaluating rumors.

Meanwhile, we are continuing to focus on working with our teams of consultants on activities related to the review by the Medicines and Healthcare Products Regulatory Agency (MHRA) of our Marketing Authorization Application (MAA) in the UK, including preparations for inspections by the MHRA that are scheduled to take place in both the US and UK.